MedCap AB (FRA:61MA) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61MA MedCap AB FRA:61MA
96 GF Score
Price €46.70
GF Value €50.74
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedCap AB  (FRA:61MA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


MedCap AB Cyclically Adjusted PB Ratio Related Terms


MedCap AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for MedCap AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Cyclically Adjusted PB Ratio Chart

MedCap AB Annual Data
Trend Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedCap AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.27 11.46 10.06 8.39 9.08

FRA:61MA vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, MedCap AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MedCap AB's Cyclically Adjusted PB Ratio falls into.


FRA:61MA
96GF Score
MedCap AB FRA:61MA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

MedCap AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, MedCap AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.515/134.6100*134.6100
=9.515

Current CPI (Jun. 2026) = 134.6100.

MedCap AB Quarterly Data

Book Value per Share CPI Adj_Book
201510 2.285 100.301 3.067
201601 2.334 99.931 3.144
201604 2.503 100.732 3.345
201607 2.416 101.080 3.217
201610 2.334 101.485 3.096
201701 2.285 101.326 3.036
201803 2.034 103.962 2.634
201806 2.019 104.875 2.591
201809 2.047 105.679 2.607
201812 2.008 105.912 2.552
201903 2.118 105.886 2.693
201906 2.199 106.742 2.773
201909 2.255 107.214 2.831
201912 2.355 107.766 2.942
202003 2.368 106.563 2.991
202006 3.737 107.498 4.680
202009 3.810 107.635 4.765
202012 4.049 108.296 5.033
202103 4.038 108.360 5.016
202106 4.089 108.928 5.053
202109 4.271 110.338 5.211
202112 4.576 112.486 5.476
202203 4.853 114.825 5.689
202206 4.856 118.384 5.522
202209 5.047 122.296 5.555
202212 5.215 126.365 5.555
202303 5.309 127.042 5.625
202306 5.445 129.407 5.664
202309 5.770 130.224 5.964
202312 6.231 131.912 6.358
202403 6.421 132.205 6.538
202406 6.855 132.716 6.953
202409 7.152 132.304 7.277
202412 7.604 132.987 7.697
202503 8.073 132.825 8.182
202506 8.097 133.699 8.152
202509 8.457 133.480 8.529
202512 8.972 133.380 9.055
202603 9.265 133.550 9.339
202606 9.515 134.610 9.515

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is MedCap AB (FRA:61MA) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of €46.70 is trading 8% below its estimated GF Value™ of €50.74. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for FRA:61MA:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €50.74 vs. price of €46.70 (8% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the FRA:61MA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
96GF Score

Get the complete analysis for FRA:61MA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.70
Price
€50.74
GF Value